Identification and differentiation of Candida species from pediatric patients by random amplified polymorphic DNA

Rev Soc Bras Med Trop. 2008 Jan-Feb;41(1):1-5. doi: 10.1590/s0037-86822008000100001.

Abstract

Thirty-four Candida isolates were analyzed by random amplified polymorphic DNA using the primer OPG-10:24 Candida albicans; 4 Candida tropicalis; 2 Candida parapsilosis; 2 Candida dubliniensis; 1 Candida glabrata and 1 Candida krusei. The UPGMA-Pearson correlation coefficient was used to calculate the genetic distance between the different Candida groupings. Samples were classified as identical (correlation of 100%); highly related samples (90%); moderately related samples (80%) and unrelated samples (< 70%). The results showed that the RAPD proposed was capable of classifying the isolates coherently (such that same species were in the same dendrogram), except for two isolates of Candida parapsilosis and the positive control (Netherlands, 1973), probably because they are now recognized as three different species. Concerning the only fluconazole-resistant Candida tropicalis isolate with a genotype that was different to the others, the data were insufficient to affirm that the only difference was the sensitivity to fluconazole. We concluded that the Random Amplified Polymorphic DNA proposed might be used to confirm Candida species identified by microbiological methods.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology
  • Candida / classification*
  • Candida / drug effects
  • Candida / genetics
  • DNA Primers / genetics
  • DNA, Fungal / genetics
  • Fluconazole / pharmacology
  • Genotype
  • Humans
  • Mycological Typing Techniques
  • Random Amplified Polymorphic DNA Technique

Substances

  • Antifungal Agents
  • DNA Primers
  • DNA, Fungal
  • Fluconazole